Loading...
Vaccinex, Inc.
VCNX•NASDAQ
Healthcare
Biotechnology
$0.71
$-0.29(-28.99%)
Vaccinex, Inc. (VCNX) Financial Performance & Statements
Review Vaccinex, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
5.44%
↑ 5.44%
Operating Income Growth
18.13%
↑ 18.13%
Net Income Growth
7.98%
↑ 7.98%
Operating Cash Flow Growth
6.08%
↑ 6.08%
Operating Margin
-3117.30%
↓ 3117.30%
Gross Margin
-547.42%
↓ 547.42%
Net Profit Margin
-3100.50%
↓ 3100.50%
ROE
1855.05%
↑ 1855.05%
ROIC
753.01%
↑ 753.01%
Vaccinex, Inc. (VCNX) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Vaccinex, Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $213000.00 | $52000.00 | $232000.00 | $104000.00 |
| Cost of Revenue | $0.00 | $0.00 | $3.86M | $27000.00 |
| Gross Profit | $213000.00 | $52000.00 | -$3.63M | $77000.00 |
| Gross Profit Ratio | $1.00 | $1.00 | -$15.66 | $0.74 |
| R&D Expenses | $2.13M | $3.17M | $3.86M | $3.38M |
| SG&A Expenses | $1.47M | $1.44M | $2.09M | $1.79M |
| Operating Expenses | $3.60M | $4.60M | $5.95M | $5.18M |
| Total Costs & Expenses | $3.60M | $4.60M | $5.95M | $5.18M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $2000.00 | $0.00 | $0.00 | $28000.00 |
| Depreciation & Amortization | $17000.00 | $24000.00 | $25000.00 | $27000.00 |
| EBITDA | -$3.35M | -$5.71M | -$5.61M | -$3.84M |
| EBITDA Ratio | -$15.75 | -$109.77 | -$24.16 | -$36.94 |
| Operating Income | -$3.39M | -$4.55M | -$5.72M | -$5.07M |
| Operating Income Ratio | -$15.90 | -$87.54 | -$24.66 | -$48.79 |
| Other Income/Expenses (Net) | $13000.00 | -$1.18M | $91000.00 | $1.18M |
| Income Before Tax | -$3.37M | -$5.73M | -$5.63M | -$3.90M |
| Income Before Tax Ratio | -$15.84 | -$110.23 | -$24.27 | -$37.47 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | -$27000.00 |
| Net Income | -$3.37M | -$5.73M | -$5.63M | -$3.90M |
| Net Income Ratio | -$15.84 | -$110.23 | -$24.27 | -$37.47 |
| EPS | -$1.61 | -$2.83 | -$3.10 | -$2.94 |
| Diluted EPS | -$1.61 | -$2.83 | -$3.10 | -$2.94 |
| Weighted Avg Shares Outstanding | $2.10M | $2.03M | $1.82M | $1.33M |
| Weighted Avg Shares Outstanding (Diluted) | $2.10M | $2.03M | $1.82M | $1.33M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan